watch
Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc.

Sector: Pharmaceutical Preparations Region: PA, United States


: | NYSE MKT: HEB


Similar to: Mast Therapeutics, Inc., Sanofi, BioGaia AB

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in treating and preventing chronic viral and immune-based disorders through the development and manufacturing of compounds that enhance the natural immune system of the human body. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.

News & Analysis

You may also be interested in: